KALA BIO reports Q3 results
- KALA BIO press release (KALA): Q3 Net loss of approximately $0.8 million for the third quarter of 2026, compared to $7.6 million for the third quarter of 2025.
- Net loss of approximately $4.0 million for the nine months ended September 30, 2026, compared to $27.7 million for the same period in 2025.
- Cash, cash equivalents and short-term investments of approximately $7.0 million as of September 30, 2026, with no debt.
More on KALA BIO
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.